“Friendly staff. Dr. Schwartz explains things very well. Very clean facility.”
Macular Hemorrhage in AMD: Urgent Care for Sudden Vision Loss
Who Is at Risk
Macular hemorrhage most commonly affects older adults, particularly those already living with wet AMD. Several factors can raise the likelihood of experiencing this complication. Being aware of your personal risk factors helps you and your retina specialist stay proactive.
Adults between the ages of 65 and 90 who have wet AMD carry the highest risk. However, for some patients, a sudden macular hemorrhage is the first sign that wet AMD is present, occurring before any formal diagnosis has been made. If you are in this age group and notice any sudden change in central vision, it should be treated as an emergency regardless of whether you have a prior AMD diagnosis.
Patients who take antiplatelet or anticoagulant medications (commonly called blood thinners) face a significantly higher risk of macular hemorrhage. Research has shown that this risk can be more than four times higher in people using daily blood thinners compared to those who are not.
If you take blood thinners for heart disease, atrial fibrillation, or stroke prevention, share this information with your retina specialist. Stopping blood thinners without medical guidance can be dangerous. Any decision to adjust these medications must involve both your retina specialist and the physician who prescribed them.
Even patients who are already receiving anti-VEGF injections for wet AMD can experience a macular hemorrhage. A gap or extension in the injection schedule, or an unexpected change in disease activity, can allow abnormal vessels to bleed. Recurrence is also a real concern, with studies showing that roughly half of patients who have had one submacular hemorrhage may experience another over time. Consistent treatment and regular monitoring are the most effective tools against this risk.
Recognizing the Symptoms
The symptoms of a macular hemorrhage are sudden and often alarming. Because vision damage can occur within hours, knowing what to look for and acting immediately is critical. Do not wait to see if symptoms improve on their own.
The most recognizable symptom is a rapid, severe loss of central vision in one eye. Many patients experience a dramatic decline in visual clarity, often to a level considered legally blind. This vision loss typically occurs without any pain, which can make it feel disorienting and unexpected. Any sudden loss of central vision is a medical emergency.
Alongside central vision loss, patients may notice additional warning signs that something is wrong. These can appear alone or together.
- A dark or blank spot in the center of your vision
- Straight lines appearing wavy or bent (a symptom called metamorphopsia)
- A sudden increase in floaters, which are small dark shapes drifting across your visual field
- In rare cases, a shadow or curtain moving across your peripheral vision if blood enters the vitreous cavity
Blood beneath the macula begins damaging photoreceptors rapidly. The longer blood sits under the macula, the greater the risk of permanent cell loss. Larger and thicker hemorrhages are consistently linked to worse outcomes. Reaching a retina specialist as quickly as possible gives your vision the best chance of being preserved.
How a Macular Hemorrhage Is Diagnosed
Accurate diagnosis requires a combination of a thorough clinical exam and advanced retinal imaging. Our team uses a full range of diagnostic tools to evaluate the hemorrhage and identify its cause. This information directly guides which treatment approach is best for each patient.
A retina specialist will begin with a dilated eye exam, using special lenses and a bright light to view the back of the eye. A submacular hemorrhage typically appears as a dark red or brownish area beneath the central retina. The size, thickness, and exact location of the blood help determine how urgent treatment is and which approach to recommend.
Advanced imaging provides detailed information that a clinical exam alone cannot capture. Optical coherence tomography (OCT) creates precise cross-sectional images of the retinal layers, revealing exactly where the blood is located, how thick it is, and whether fluid is present. Fluorescein angiography (FA) uses a dye injected into a vein in the arm to highlight leaking blood vessels and pinpoint the source of the hemorrhage.
Indocyanine green angiography (ICG) evaluates deeper blood vessels beneath the retina and is especially useful when polypoidal choroidal vasculopathy is suspected. Wide-field imaging and B-scan ultrasound may also be used depending on the clinical picture. Our team performs all of these imaging studies in our offices.
Because several conditions can cause a macular hemorrhage, identifying the correct underlying cause is an essential step. In most older adults, wet AMD is the primary driver. However, findings from imaging and the clinical exam may indicate a different cause, such as PCV, a ruptured macroaneurysm, or trauma. The correct diagnosis ensures the right treatment is applied from the start.
Treatment Options
Treatment for macular hemorrhage aims to remove or displace the blood from under the macula and address the condition causing the bleeding. The most appropriate approach depends on the size and thickness of the hemorrhage, how long it has been present, and the patient's overall health. Our team will walk you through the options that apply to your situation.
Anti-VEGF injections are a central part of treatment for wet AMD and its complications, including macular hemorrhage. These medications block the VEGF protein that drives abnormal blood vessel growth and leaking. The anti-VEGF agents used in our practice include Avastin (bevacizumab), Lucentis (ranibizumab), Eylea (aflibercept), and Vabysmo (faricimab). Each works to stabilize the underlying disease, help stop further bleeding, and support resorption of the blood already present.
For smaller hemorrhages, anti-VEGF monotherapy may be sufficient to stabilize the condition and gradually allow blood to absorb. Larger hemorrhages typically require additional intervention alongside injections.
Pneumatic displacement is a less invasive procedure that can be performed in the office. A small gas bubble is injected into the vitreous cavity (the gel-filled space inside the eye). This bubble exerts gentle pressure that moves blood away from the center of the macula, allowing the photoreceptors underneath to recover.
This technique is often combined with tissue plasminogen activator (tPA), a clot-dissolving medication that helps liquefy the blood so it moves more easily. After the procedure, patients are asked to maintain a specific head position for several days to keep the gas bubble positioned correctly over the macula. Research has shown that pneumatic displacement combined with anti-VEGF therapy can lead to meaningful vision improvement without the risks of more invasive surgery.
For larger or thicker hemorrhages, pars plana vitrectomy (PPV) may be recommended. This is a surgical procedure in which the vitreous gel is removed from inside the eye, giving the surgeon access to inject tPA directly beneath the retina to dissolve the clot. An air or gas bubble is then placed inside the eye to help flatten the retina and support healing.
Anti-VEGF medication may also be delivered directly beneath the retina during surgery to further address the underlying blood vessel disease. Vitrectomy is typically performed in an outpatient surgical setting. The gas bubble placed during surgery gradually dissolves over weeks, and patients must avoid air travel and certain types of anesthesia during that time.
Both pneumatic displacement and vitrectomy, when combined with anti-VEGF therapy, have shown meaningful visual improvements in patients with macular hemorrhage. Neither approach is universally superior. The decision depends on the size and age of the hemorrhage, the patient's overall health, and the clinical judgment of the retina specialist. Your care team will discuss the risks and expected benefits of each option with you clearly before any procedure.
Managing Long-Term Risk
Living with wet AMD means staying actively engaged in monitoring and treatment over the long term. Macular hemorrhage can recur, and the most effective defense is consistent care. There are several practical habits and steps that can help protect your vision going forward.
An Amsler grid is a simple visual tool with a pattern of straight lines and a center dot. Holding it at reading distance and covering one eye at a time, look directly at the center dot. If any lines appear wavy, distorted, broken, or missing, contact your retina specialist right away. This daily habit takes only seconds but can help catch early changes before they become a larger problem. Check each eye separately every morning.
Ongoing anti-VEGF injections are essential to keeping the abnormal blood vessels under control. Even when your vision feels stable, the injections are working to suppress vessel activity beneath the surface. Missing or delaying appointments can allow those vessels to become active again and increase the risk of another hemorrhage. If scheduling becomes difficult, talk with our team about extended dosing options or alternative arrangements.
Make sure your retina specialist knows about every medication you are taking, especially blood thinners. These medications are often prescribed for life-threatening conditions and cannot simply be stopped. Having an open conversation allows your retina specialist and prescribing physician to weigh the risks together and make the safest decision for your overall health.
Frequently Asked Questions
The following questions address common concerns about macular hemorrhage that patients often bring to their appointments.
You should seek care the same day symptoms appear, not the following morning or after a weekend. Blood beneath the macula causes photoreceptor damage within hours through a combination of clot pressure, iron toxicity, and nutrient deprivation. If you cannot immediately reach a retina specialist, go to the nearest emergency room and ask for an urgent ophthalmology or retina consult. Every hour matters in preserving what vision remains.
Recovery depends on how long blood was present under the macula before treatment began, the size of the hemorrhage, and how much photoreceptor damage occurred before intervention. Some patients regain meaningful central vision, while others experience lasting limitations despite excellent care. Treatment significantly improves the likelihood of a better outcome compared to no treatment, but specific results cannot be promised. Your retina specialist will give you a realistic picture based on your imaging and exam findings.
Do not stop taking blood thinners on your own. These medications are often prescribed to prevent life-threatening events such as stroke or cardiac events, and stopping them abruptly carries serious risks of its own. What you should do is make sure both your prescribing physician and your retina specialist are aware of your full medication list. Any adjustment to your blood thinner regimen needs to be a coordinated decision that accounts for your entire medical picture, not just your eye health.
Pneumatic displacement is performed in the office and involves injecting a gas bubble into the eye to physically shift blood away from the macula. It is less invasive and recovery is generally faster, but it requires you to hold a specific head position for several days. Vitrectomy is a surgical procedure done in an operating room, where the vitreous gel is removed and clot-dissolving medication is applied directly. It is better suited for larger or thicker hemorrhages that cannot be managed with the office-based approach alone. Both methods are combined with anti-VEGF injections and have shown similar overall outcomes in appropriate patients.
Yes, recurrence is a recognized concern with wet AMD. Studies suggest that roughly half of patients who experience a submacular hemorrhage may have another within a few years without adequate disease management. The most reliable way to lower that risk is to maintain your anti-VEGF injection schedule, monitor your vision daily with an Amsler grid, and report any new visual symptoms immediately. Recurrence does not mean treatment has failed, but it does reinforce the importance of ongoing, uninterrupted care.
Wet AMD is a chronic condition, and for most patients, long-term anti-VEGF treatment is needed to keep the disease under control. The frequency of injections often changes over time as your retina specialist adjusts the schedule based on how your eyes respond and what the imaging shows at each visit. Some patients are able to extend time between injections with close monitoring. The goal is always to use the minimum treatment needed to maintain stability, while ensuring protection against future bleeding.
Schedule a Visit with Atlantic Retina Center
If you are experiencing sudden vision changes or have been diagnosed with wet AMD, our team at Atlantic Retina Center is here to help. We specialize exclusively in diseases of the retina, vitreous, and macula, and our retina specialists bring focused expertise to every aspect of your care. We see patients across the Eastern Shore of Maryland and central and southern Delaware, with multiple office locations designed to make access as convenient as possible. Contact us to schedule an appointment and take the next step toward protecting your vision.